Posted: November 24, 2011 at 5:49 pm
William Bruyea, host of StemCellTV talks to Dr. Craig Saunders of Harmony Cosmetic Surgery in Keller, TX about Stem Cell Education at the Evolution of Fat Workshop held at the Martin Lawrence Art Gallery in Dallas, TX sponsored by Medical Alliance Services, distributor of Tickle Lipo.
Read more here:
Craig Saunders Discusses Stem Cell Education at the Evolution of Fat Workshop in Dallas, TX - Video
Posted: November 24, 2011 at 3:28 am
Stem Cell Therapy in the Treatment of Patients with Ischemic Heart Failure Emerson Perin, MD, PhD., Director, Clinical Research for Cardiovascular Medicine and the Medical Director of the Stem Cell Center, Texas Heart Institute, St. Luke's Episcopal Hospital Scientific advancements in the stem cell field can lead to new treatments and therapies for diseases and medical disorders for which we have few or no effective medications or treatment options. The emerging field of regenerative medicine capitalizes on unparalleled collaboration among leading scientists, requires innovative technologies and holds the potential to benefit society through improved health care, disease prevention and treatment
Posted: November 23, 2011 at 5:33 pm
Stem Cell Therapy in the Treatment of Patients with Ischemic Heart Failure Emerson Perin, MD, PhD., Director, Clinical Research for Cardiovascular Medicine and the Medical Director of the Stem Cell Center, Texas Heart Institute, St. Luke's Episcopal Hospital Scientific advancements in the stem cell field can lead to new treatments and therapies for diseases and medical disorders for which we have few or no effective medications or treatment options. The emerging field of regenerative medicine capitalizes on unparalleled collaboration among leading scientists, requires innovative technologies and holds the potential to benefit society through improved health care, disease prevention and treatment.
More here:
Austin Forum - Nov 1st (Part 2 of 4) - Video
Posted: November 23, 2011 at 5:32 pm
Stem Cell Therapy in the Treatment of Patients with Ischemic Heart Failure Emerson Perin, MD, PhD., Director, Clinical Research for Cardiovascular Medicine and the Medical Director of the Stem Cell Center, Texas Heart Institute, St.
See original here:
Austin Forum - Nov 1st (Part 4 of 4) - Video
Posted: November 23, 2011 at 10:52 am
See more here:
Newest Advances in Adult Stem Cell Research - Video
Posted: November 20, 2011 at 7:12 pm
Tommy Thompson says the race for US Senate is his to win if he gets the Republican nomination.
Go here to read the rest:
Thompson Defends Claims He's Flip-Flopped On Stem Cell Research - Video
Posted: November 20, 2011 at 5:03 pm
(HealthDay News) -- Methods to gauge blood cholesterol to determine vascular disease risk can be simplified, researchers in England say.
Their method measures levels of either total or high-density lipoprotein (HDL, or "good" cholesterol) in the blood or apolipoproteins (proteins that help transport cholesterol), without the need to have patients fast and without regard to another form of blood fat called triglycerides.
"Expert opinion is divided" on which combination of measurements is ideal in gauging cardiovascular risk, explained John Danesh, of the Emerging Risk Factors Collaboration Coordinating Centre at the University of Cambridge, and colleagues.
In order to examine the association between major blood fats and apolipoproteins and coronary heart disease and ischemic stroke, the researchers analyzed data on more than 300,000 people without initial vascular disease who took part in 68 long-term studies.
During the follow-up periods of the studies, there were almost 8,900 nonfatal heart attacks, more than 3,900 coronary heart disease deaths, over 2,500 ischemic strokes, 513 hemorrhagic strokes and more than 2,500 unclassified strokes, the study authors noted.
The analysis of the data yielded a number of findings. Read more...
Ayurtox for Body Detoxification
Posted: November 20, 2011 at 5:03 pm
The patient had endured 20 years of pain: her calves had turned into two bricks, and she now had trouble walking. A slew of doctors had failed to treat, let alone diagnose, her unusual condition. So when her x-rays finally landed on William A. Gahl’s desk at the National Institutes of Health, he knew immediately that he had to take her case.
Gahl is the scientist and physician who leads the Undiagnosed Diseases Program, which tries to unravel the underlying causes of, and find therapies for, mysterious maladies and known but rare conditions. Louise Benge’s x-rays had revealed that blood vessels in her legs and feet bore a thick coat of calcium that restricted blood flow. Benge’s sister, Paula Allen, along with several other members of the family, also shared the disorder. Over the course of several months Gahl identified the genetic root of the disorder--a mutation in a gene that regulates calcium--and he went on to propose a treatment with drugs already on the market. He continues to assess the treatment’s value.
Posted: November 20, 2011 at 5:03 pm
Source:
http://intlstemcell.blogspot.com/feeds/posts/default?alt=rss
Posted: November 20, 2011 at 5:03 pm
Source:
http://intlstemcell.blogspot.com/feeds/posts/default?alt=rss
Source: